[PDF][PDF] Identification of early gene expression profiles associated with long-lasting antibody responses to the Ebola vaccine Ad26. ZEBOV/MVA-BN-Filo
F Blengio, H Hocini, L Richert, C Lefebvre, M Durand… - Cell Reports, 2023 - cell.com
Ebola virus disease is a severe hemorrhagic fever with a high fatality rate. We investigate
transcriptome profiles at 3 h, 1 day, and 7 days after vaccination with Ad26. ZEBOV and MVA …
transcriptome profiles at 3 h, 1 day, and 7 days after vaccination with Ad26. ZEBOV and MVA …
[HTML][HTML] STAGEs: A web-based tool that integrates data visualization and pathway enrichment analysis for gene expression studies
Gene expression profiling has helped tremendously in the understanding of biological
processes and diseases. However, interpreting processed data to gain insights into …
processes and diseases. However, interpreting processed data to gain insights into …
A Bivalent Bacterium‐like Particles‐Based Vaccine Induced Potent Immune Responses against the Sudan Virus and Ebola Virus in Mice
S Xu, W Li, C Jiao, Z Cao, F Wu, F Yan… - Transboundary and …, 2023 - Wiley Online Library
Ebola virus disease (EVD) is an acute viral hemorrhagic fever disease causing thousands of
deaths. The large Ebola outbreak in 2014–2016 posed significant threats to global public …
deaths. The large Ebola outbreak in 2014–2016 posed significant threats to global public …
[PDF][PDF] Global blood miRNA profiling unravels early signatures of immunogenicity of Ebola vaccine rVSVΔG-ZEBOV-GP
E Vianello, J Persson, B Andersson, S van Veen… - iScience, 2023 - cell.com
The vectored Ebola vaccine rVSVΔG-ZEBOV-GP elicits protection against Ebola Virus
Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the …
Disease (EVD). In a study of forty-eight healthy adult volunteers who received either the …
A Recombinant Vesicular Stomatitis Virus–Based Vaccine Provides Postexposure Protection Against Bundibugyo Ebolavirus Infection
C Woolsey, J Strampe, KA Fenton… - The Journal of …, 2023 - academic.oup.com
Abstract Background The filovirus Bundibugyo virus (BDBV) causes severe disease with a
mortality rate of approximately 20%–51%. The only licensed filovirus vaccine in the United …
mortality rate of approximately 20%–51%. The only licensed filovirus vaccine in the United …